Radiosensitivity is a term used to designate the reaction of cells to radiation, and the radiotherapy of malignant disease is based upon the difference in radiosensitivity between neoplastic cells and the normal cells which surround them.
The factors that enter into radiosensitivity are many. The general condition of the patient often has a most important influence on the behavior of the tumor under treatment, and the metabolic activities of tumor cells are likewise important in determining sensitivity. There is a definite relationship between the grade of malignancy of a tumor and its reaction to radiation, since the latter is in direct ratio to the rapidity of its growth. Indeed, the law of Bergonie and Tribondeau states that tumors composed of rapidly multiplying cells, especially those of the embryonal type, are highly susceptible to radiation.
From the practical point of view, radiologists consider the embryonal type of tumor especially favorable to radiation; adenoma and adenocarcinoma have a tendency to produce glandular structures which render them more resistant; epidermoid carcinoma, arising from squamous cells, is markedly radiosensitive; and osteogenic and neurogenic sarcomas are the most resistant of neoplasms.
The location of a tumor is often an important factor in its reaction. Tumors growing in bone are many times invulnerable to repeated radiation, and mammary tumors, because of their growth in the fatty tissues of the breast and axilla, are extremely difficult to treat.
In addition to these factors resident within the tumor itself or based upon its location, many other conditions contribute to the sensitivity or resistance of the tumors to radiation. Among these may be mentioned active infection, which interferes with successful radiation; indeed, the inflammatory process may be aggravated, and in many instances the growth of the tumor cells is accelerated . In cancer of the mouth, microbial infection unfavorably influences efforts to control maligniancy.
The general condition of the patient also exerts an effect upon the results of radiation, and it has been suggested that possibly the activity of the endocrine glands may play some role in the tissue reaction. Tumors, in patients with anemia and cachexia, may fail to respond to an intensive radiation which, in patients with good general health is effective.
Clinical experience and experimental evidence have demonstrated the fact that neoplastic cells may develop an acquired resistance to radiation following successive inadequate dosage, and this should be very seriously considered by those assuming the responsibility for radiation therapy. We all too frequently encounter indolent tumors that, following a long succession of treatments by radium or X-ray, have become so resistant to radiation that they fail to respond favorably, even to very high dosage. The explanation of this phenomenon is difficult, but the fact remains that repeated insufficient treatments by radiation diminish the radiosensitiveness of human cancer.
To cure some neoplasms it is necessary to give a radiation dose that is sufficient to destroy epidermis; for example, in radium treatment of malignancies of the skin, the mouth, and the vagina, there is a fair margin of safety with what we may determine to be the sterilizing dose. If a severe reaction, comparable perhaps to a second degree burn, is produced in the marginal zone of supporting epidermis, it is unimportant, since it heals quickly. On the other hand, the death of connective tissue stroma resulting from radium necrosis, presents a serious complication.
The varying radiosensitivity of neoplasms precludes the formulation of a definite cancer dose of radiant energy. Skin erythema lacks the precision necessary for establishing a standard unit. It has been accepted generally, in accord with Regaud's suggestion, that a dose sufficient to cause a suppression of spermatogenesis in the testes, which is analogous to the dose required to cause shedding of the epidermis, be considered a standard unit. This phenomenon, as he observes, is more evident and more clearly defined than is the erythema of the skin resulting from radiation, and the limits of the dose that will produce it vary less than do those of the dose that will cause an erythema. The dose necessary to sterilize a certain neoplasm is given as a percentage of the epidermicidal dose.
In considering this subject, it is essential to remember that the growth of cancer depends upon an indefinite multiplication of cells;
that in the beginning, cancer is a localized disease, and in that stage is amenable to radiation. Outside of the zone of clinically apparent cancer, there is a latent zone of implantation, discernible only microscopically. Whether we elect to treat the neoplasm surgically or by radiation, this outer zone must be effectually treated, marginal recurrences being frequent. If the malignancy is to be treated by radiation, every part of the neoplasm must be given a lethal dose. If the limit of radiosensibility of the normal surrounding structure is exceeded, a lesion of the epithelium will occur. It follows, therefore, that extreme accuracy of dosage and treatment is required of the radiotherapist. It is useless to subject patients to large doses of radiation when the tumor is of the type that is highly resistant and, on the other hand, patients should be spared too heavy radiation if lighter doses will suffice.
